Orion Properties Inc. (“Orion” or the “Company”) (NYSE: ONL) today announced that it has entered into a new $215 million senior secured revolving credit facility and extended its existing $355 million ...
BOSTON, Jan. 08, 2026 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for ...
Ensysce Biosciences (ENSC) issued its 2025 annual letter to shareholders from CEO Lynn Kirkpatrick, which read in part, “2025 was a year of meaningful execution and strategic advancement for Ensysce.
The MarketWatch News Department was not involved in the creation of this content. Singapore, Jan. 12, 2026 (GLOBE NEWSWIRE) -- GlobalTech Horizons Asia (GTH-Asia), in collaboration with JYSigma ...